← Leaderboards
Thomas H Sisson
University Of Michigan At Ann Arbor
$6,987,602
Attributed
$9,264,668
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2007–25$2M$1.5M$1M$500K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,264,668 · 4
By mechanism
R01$8,597,359 · 3
K08$667,309 · 1
Top collaborators
- Kevin Keewoun Kim4 shared
- Daniel A Lawrence3 shared
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Sem H Phan$21,667,175
- Robert M Strieter$9,675,893
- Galen B Toews$14,158,453
- Theodore J. Standiford$19,414,687
- Jeffrey C Horowitz$5,320,602
Others in their field
Top investigators on “Plasminogen Activator”
- Joseph Paul Broderick · University Of Cincinnati$18,831,259
- Guy L Reed · Harvard University (Sch Of Public Hlth)$18,181,726
- Jeffrey L Saver · University Of California Los Angeles$16,373,833
- Daniel A Lawrence · University Of Michigan At Ann Arbor$16,210,511
- Daniel F Hanley · Johns Hopkins University$14,357,371
- Douglas Eugene Vaughan · Vanderbilt University$14,319,046
Research focus
Plasminogen ActivatorBleomycinCellsMediatingLungPulmonary FibrosisLung InjuryCicatrixFibrosisEpithelial CellsLung DiseasesAlveolarPathogenesisProteinsPlasminogen Activator Inhibitor 1PhenotypeSeveritiesFibroblastsVitronectinFibrogenesisIn VitroAnimal ModelNovel TherapeuticsPathway Interactions
Grant awards (22)
A Novel PAI-1 Function Drives Lung Fibrosis$706,535
R01 · FY2025 · HL · contact PI
A Novel PAI-1 Function Drives Lung Fibrosis$695,226
R01 · FY2024 · HL · contact PI
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$604,667
R01 · FY2024 · HL
A Novel PAI-1 Function Drives Lung Fibrosis$696,684
R01 · FY2023 · HL · contact PI
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$617,007
R01 · FY2023 · HL
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$617,007
R01 · FY2022 · HL
Oxidized Phospholipids Derived from Apoptotic Pneumocytes Drives Macrophage Activation and Initiates Lung Fibrosis$617,007
R01 · FY2021 · HL
Somatomedin B Binding of Plasminogen Activator Inhibitor-1 in Pulmonary Fibrosis$450,793
R01 · FY2018 · HL · contact PI
Somatomedin B Binding of Plasminogen Activator Inhibitor-1 in Pulmonary Fibrosis$450,793
R01 · FY2017 · HL · contact PI
Somatomedin B Binding of Plasminogen Activator Inhibitor-1 in Pulmonary Fibrosis$450,793
R01 · FY2016 · HL · contact PI
Somatomedin B Binding of Plasminogen Activator Inhibitor-1 in Pulmonary Fibrosis$444,030
R01 · FY2015 · HL · contact PI
Somatomedin B Binding of Plasminogen Activator Inhibitor-1 in Pulmonary Fibrosis$457,247
R01 · FY2014 · HL · contact PI
The Anti-protease and Vitronectin-binding Functions of PAI-1 in Lung Fibrosis$356,590
R01 · FY2011 · HL · contact PI
The Anti-protease and Vitronectin-binding Functions of PAI-1 in Lung Fibrosis$357,271
R01 · FY2010 · HL · contact PI
The Anti-protease and Vitronectin-binding Functions of PAI-1 in Lung Fibrosis$357,933
R01 · FY2009 · HL · contact PI
The Anti-protease and Vitronectin-binding Functions of PAI-1 in Lung Fibrosis$358,576
R01 · FY2008 · HL · contact PI
The Anti-protease and Vitronectin-binding Functions of PAI-1 in Lung Fibrosis$359,200
R01 · FY2007 · HL · contact PI
PLASMIN, FIBRIN, AND METALLOPROTEINASES IN LUNG FIBROSIS$133,434
K08 · FY2004 · HL
PLASMIN, FIBRIN, AND METALLOPROTEINASES IN LUNG FIBROSIS$133,448
K08 · FY2003 · HL
PLASMIN, FIBRIN, AND METALLOPROTEINASES IN LUNG FIBROSIS$133,462
K08 · FY2002 · HL
PLASMIN, FIBRIN, AND METALLOPROTEINASES IN LUNG FIBROSIS$133,476
K08 · FY2001 · HL
PLASMIN, FIBRIN, AND METALLOPROTEINASES IN LUNG FIBROSIS$133,489
K08 · FY2000 · HL